Amber Umble-Romero
Amgen (United States)(US)Seattle University(US)
Research Areas
Biosimilars and Bioanalytical Methods, T-cell and B-cell Immunology, Computational Drug Discovery Methods, Psoriasis: Treatment and Pathogenesis, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → Preclinical development ofAMG139, a human antibody specifically targetingIL‐23(2014)31 cited
- → Characterization of a quantitative method to measure free proprotein convertase subtilisin/kexin type 9 in human serum(2014)20 cited
- → Bioanalytical strategy used in development of pharmacokinetic (PK) methods that support biosimilar programs(2014)18 cited